ReP USP - Resultado da busca

Artigo de periodico
Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein (2023)
Bitencourt, Natália Vitória ; Righetto, Gabriela Marinho; Camargo, Ilana Lopes Baratella da Cunha ; Godoy, Mariana Ortiz de ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Santos Filho, Norival Alves ; Cilli, Eduardo Maffud
Source: Pharmaceutics. Unidade: IFSC
Subjects: COVID-19, CORONAVIRUS, PEPTÍDEOS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITENCOURT, Natália Vitória et al. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, v. 15, n. 2, p. 436-1-436-17 + supplementary materials: 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15020436. Acesso em: 01 nov. 2024.
APA
Bitencourt, N. V., Righetto, G. M., Camargo, I. L. B. da C., Godoy, M. O. de, Guido, R. V. C., Oliva, G., et al. (2023). Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, 15( 2), 436-1-436-17 + supplementary materials: 1-8. doi:10.3390/pharmaceutics15020436
NLM
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/pharmaceutics15020436
Vancouver
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/pharmaceutics15020436
Artigo de periodico
Drug repurposing of the antiviral drug acyclovir: new pharmaceutical salts (2023)
Souza, Paulo Nunes de; Santiago, Pedro Henrique de Oliveira; Silva, Cecília Carolina Pinheiro da ; Ellena, Javier
Source: Crystals. Unidade: IFSC
Subjects: FÁRMACOS, COVID-19, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Paulo Nunes de et al. Drug repurposing of the antiviral drug acyclovir: new pharmaceutical salts. Crystals, v. 13, n. 5, p. 782-1-782-15, 2023Tradução . . Disponível em: https://doi.org/10.3390/cryst13050782. Acesso em: 01 nov. 2024.
APA
Souza, P. N. de, Santiago, P. H. de O., Silva, C. C. P. da, & Ellena, J. (2023). Drug repurposing of the antiviral drug acyclovir: new pharmaceutical salts. Crystals, 13( 5), 782-1-782-15. doi:10.3390/cryst13050782
NLM
Souza PN de, Santiago PH de O, Silva CCP da, Ellena J. Drug repurposing of the antiviral drug acyclovir: new pharmaceutical salts [Internet]. Crystals. 2023 ; 13( 5): 782-1-782-15.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/cryst13050782
Vancouver
Souza PN de, Santiago PH de O, Silva CCP da, Ellena J. Drug repurposing of the antiviral drug acyclovir: new pharmaceutical salts [Internet]. Crystals. 2023 ; 13( 5): 782-1-782-15.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/cryst13050782
Parte de monografia/livro
Productivity in times of Covid-19: an agent-based model approach (2022)
Fontanari, José Fernando
Source: Predicting pandemics in a globally connected world: toward a multiscale, multidisciplinary framework through modeling and simulation. Unidade: IFSC
Subjects: COVID-19, CORONAVIRUS, PRODUTIVIDADE, INTERAÇÃO SOCIAL (COMPORTAMENTO SOCIAL)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONTANARI, José Fernando. Productivity in times of Covid-19: an agent-based model approach. Predicting pandemics in a globally connected world: toward a multiscale, multidisciplinary framework through modeling and simulation. Tradução . Cham: Springer, 2022. v. 1. . Disponível em: https://doi.org/10.1007/978-3-030-96562-4_7. Acesso em: 01 nov. 2024.
APA
Fontanari, J. F. (2022). Productivity in times of Covid-19: an agent-based model approach. In Predicting pandemics in a globally connected world: toward a multiscale, multidisciplinary framework through modeling and simulation (Vol. 1). Cham: Springer. doi:10.1007/978-3-030-96562-4_7
NLM
Fontanari JF. Productivity in times of Covid-19: an agent-based model approach [Internet]. In: Predicting pandemics in a globally connected world: toward a multiscale, multidisciplinary framework through modeling and simulation. Cham: Springer; 2022. [citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/978-3-030-96562-4_7
Vancouver
Fontanari JF. Productivity in times of Covid-19: an agent-based model approach [Internet]. In: Predicting pandemics in a globally connected world: toward a multiscale, multidisciplinary framework through modeling and simulation. Cham: Springer; 2022. [citado 2024 nov. 01 ] Available from: https://doi.org/10.1007/978-3-030-96562-4_7
Artigo de periodico
Quantification of a COVID-19 antibody assay using a lateral flow test and a cell phone (2022)
Thompson, Pearl; Bovolato, Ana Lívia de Carvalho ; Ibáñez-Redín, Glenda Gisela ; Brolo, Alexandre G.
Source: Chemosensors. Unidade: IFSC
Subjects: COVID-19, DIAGNÓSTICO CLÍNICO, TESTES LABORATORIAIS, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
THOMPSON, Pearl et al. Quantification of a COVID-19 antibody assay using a lateral flow test and a cell phone. Chemosensors, v. 10, n. 7, p. 234-1-234-12, 2022Tradução . . Disponível em: https://doi.org/10.3390/chemosensors10070234. Acesso em: 01 nov. 2024.
APA
Thompson, P., Bovolato, A. L. de C., Ibáñez-Redín, G. G., & Brolo, A. G. (2022). Quantification of a COVID-19 antibody assay using a lateral flow test and a cell phone. Chemosensors, 10( 7), 234-1-234-12. doi:10.3390/chemosensors10070234
NLM
Thompson P, Bovolato AL de C, Ibáñez-Redín GG, Brolo AG. Quantification of a COVID-19 antibody assay using a lateral flow test and a cell phone [Internet]. Chemosensors. 2022 ; 10( 7): 234-1-234-12.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/chemosensors10070234
Vancouver
Thompson P, Bovolato AL de C, Ibáñez-Redín GG, Brolo AG. Quantification of a COVID-19 antibody assay using a lateral flow test and a cell phone [Internet]. Chemosensors. 2022 ; 10( 7): 234-1-234-12.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/chemosensors10070234
Artigo de periodico
Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model (2022)
Sadraeian, Mohammad ; Pinto-Júnior, Fabio Francisco ; Miranda, Marcela ; Galinskas, Juliana; Fernandes, Rafaela Sachetto ; Cruz, Edgar Ferreira da; Fu, Libing; Zhang, Le ; Diaz, Ricardo Sobhie; Miranda, Gustavo Cabral de ; Guimarães, Francisco Eduardo Gontijo
Source: Pharmaceutics. Unidades: IFSC, ICB
Subjects: COVID-19, CORONAVIRUS, IMUNOLOGIA, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SADRAEIAN, Mohammad et al. Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model. Pharmaceutics, v. 14, n. 3, p. 683-1-683-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14030683. Acesso em: 01 nov. 2024.
APA
Sadraeian, M., Pinto-Júnior, F. F., Miranda, M., Galinskas, J., Fernandes, R. S., Cruz, E. F. da, et al. (2022). Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model. Pharmaceutics, 14( 3), 683-1-683-15. doi:10.3390/pharmaceutics14030683
NLM
Sadraeian M, Pinto-Júnior FF, Miranda M, Galinskas J, Fernandes RS, Cruz EF da, Fu L, Zhang L, Diaz RS, Miranda GC de, Guimarães FEG. Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model [Internet]. Pharmaceutics. 2022 ; 14( 3): 683-1-683-15.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/pharmaceutics14030683
Vancouver
Sadraeian M, Pinto-Júnior FF, Miranda M, Galinskas J, Fernandes RS, Cruz EF da, Fu L, Zhang L, Diaz RS, Miranda GC de, Guimarães FEG. Study of viral photoinactivation by UV-C light and photosensitizer using a pseudotyped model [Internet]. Pharmaceutics. 2022 ; 14( 3): 683-1-683-15.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/pharmaceutics14030683
Artigo de periodico
Development and application of an SPR nanobiosensor based on AuNPs for the detection of SARS-CoV-2 on food surfaces (2022)
Tessaro, Leticia Louize Gonçalves ; Aquino, Adriano ; Panzenhagen, Pedro ; Ochioni, Alan Clavelland; Mutz, Yhan S.; Raymundo-Pereira, Paulo Augusto ; Vieira, Italo Rennan Sousa ; Belem, Natasha Kilsy Rocha; Conte-Junior, Carlos Adam
Source: Biosensors. Unidade: IFSC
Subjects: SENSORES BIOMÉDICOS, NANOPARTÍCULAS, BIOMARCADORES, COVID-19, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TESSARO, Leticia Louize Gonçalves et al. Development and application of an SPR nanobiosensor based on AuNPs for the detection of SARS-CoV-2 on food surfaces. Biosensors, v. 12, n. 12, p. 1101-1-1101-14, 2022Tradução . . Disponível em: https://doi.org/10.3390/bios12121101. Acesso em: 01 nov. 2024.
APA
Tessaro, L. L. G., Aquino, A., Panzenhagen, P., Ochioni, A. C., Mutz, Y. S., Raymundo-Pereira, P. A., et al. (2022). Development and application of an SPR nanobiosensor based on AuNPs for the detection of SARS-CoV-2 on food surfaces. Biosensors, 12( 12), 1101-1-1101-14. doi:10.3390/bios12121101
NLM
Tessaro LLG, Aquino A, Panzenhagen P, Ochioni AC, Mutz YS, Raymundo-Pereira PA, Vieira IRS, Belem NKR, Conte-Junior CA. Development and application of an SPR nanobiosensor based on AuNPs for the detection of SARS-CoV-2 on food surfaces [Internet]. Biosensors. 2022 ; 12( 12): 1101-1-1101-14.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/bios12121101
Vancouver
Tessaro LLG, Aquino A, Panzenhagen P, Ochioni AC, Mutz YS, Raymundo-Pereira PA, Vieira IRS, Belem NKR, Conte-Junior CA. Development and application of an SPR nanobiosensor based on AuNPs for the detection of SARS-CoV-2 on food surfaces [Internet]. Biosensors. 2022 ; 12( 12): 1101-1-1101-14.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/bios12121101
Artigo de periodico
Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors (2021)
Freire, Marjorie Caroline Liberato Cavalcanti ; Noske, Gabriela Dias; Bitencourt, Natália V.; Sanches, Paulo R. S.; Santos-Filho, Norival A.; Oliveira, Victor Gawriljuk Ferraro; Souza, Eduardo Pereira de ; Nogueira, Victor Henrique Rabesquine ; Godoy, Mariana Ortiz de; Nakamura, Aline Minali; Fernandes, Rafaela Sachetto ; Godoy, Andre Schutzer de ; Juliano, Maria A.; Peres, Bianca de Miranda ; Barbosa, Cecília G.; Moraes, Carolina B.; Freitas Junior, Lucio Holanda Gondim de ; Cilli, Eduardo Maffud ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius
Source: Molecules. Unidades: IFSC, ICB
Subjects: COVID-19, CORONAVIRUS, PLANEJAMENTO DE FÁRMACOS, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREIRE, Marjorie Caroline Liberato Cavalcanti et al. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors. Molecules, v. 26, n. 16, p. 4896-1-4896-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/molecules26164896. Acesso em: 01 nov. 2024.
APA
Freire, M. C. L. C., Noske, G. D., Bitencourt, N. V., Sanches, P. R. S., Santos-Filho, N. A., Oliveira, V. G. F., et al. (2021). Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors. Molecules, 26( 16), 4896-1-4896-17. doi:10.3390/molecules26164896
NLM
Freire MCLC, Noske GD, Bitencourt NV, Sanches PRS, Santos-Filho NA, Oliveira VGF, Souza EP de, Nogueira VHR, Godoy MO de, Nakamura AM, Fernandes RS, Godoy AS de, Juliano MA, Peres B de M, Barbosa CG, Moraes CB, Freitas Junior LHG de, Cilli EM, Guido RVC, Oliva G. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors [Internet]. Molecules. 2021 ; 26( 16): 4896-1-4896-17.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/molecules26164896
Vancouver
Freire MCLC, Noske GD, Bitencourt NV, Sanches PRS, Santos-Filho NA, Oliveira VGF, Souza EP de, Nogueira VHR, Godoy MO de, Nakamura AM, Fernandes RS, Godoy AS de, Juliano MA, Peres B de M, Barbosa CG, Moraes CB, Freitas Junior LHG de, Cilli EM, Guido RVC, Oliva G. Non-Toxic dimeric peptides derived from the bothropstoxin-I are potent SARS-CoV-2 and papain-like protease inhibitors [Internet]. Molecules. 2021 ; 26( 16): 4896-1-4896-17.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/molecules26164896
Artigo de periodico
VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants (2021)
Syed, Wasim Aluisio Prates ; Chaves, Lorena C. S. ; Crema, Karin Paola; Vuitika, Larissa; Lira, Aline ; Cortês, Nelson de Angelis ; Kersten, Victor; Guimarães, Francisco Eduardo Gontijo ; Sadraeian, Mohammad ; Silva, Fernando Luís Barroso da ; Cabral-Marques, Otávio ; Barbuto, José Alexandre Marzagão ; Russo, Momtchilo ; Câmara, Niels Olsen Saraiva ; Miranda, Gustavo Cabral de
Source: Vaccines. Unidades: IFSC, FCFRP, ICB, BIOTECNOLOGIA
Subjects: COVID-19, CORONAVIRUS, VACINAS VIRAIS, IMUNOLOGIA, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SYED, Wasim Aluisio Prates et al. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants. Vaccines, v. 9, n. 12, p. 1409-1-1409-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9121409. Acesso em: 01 nov. 2024.
APA
Syed, W. A. P., Chaves, L. C. S., Crema, K. P., Vuitika, L., Lira, A., Cortês, N. de A., et al. (2021). VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants. Vaccines, 9( 12), 1409-1-1409-17. doi:10.3390/vaccines9121409
NLM
Syed WAP, Chaves LCS, Crema KP, Vuitika L, Lira A, Cortês N de A, Kersten V, Guimarães FEG, Sadraeian M, Silva FLB da, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Miranda GC de. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants [Internet]. Vaccines. 2021 ; 9( 12): 1409-1-1409-17.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/vaccines9121409
Vancouver
Syed WAP, Chaves LCS, Crema KP, Vuitika L, Lira A, Cortês N de A, Kersten V, Guimarães FEG, Sadraeian M, Silva FLB da, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Miranda GC de. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants [Internet]. Vaccines. 2021 ; 9( 12): 1409-1-1409-17.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/vaccines9121409

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Grupo de pesquisa

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration